The proinflammatory cytokine TNF-a has been shown to promote activation and sensitization of primary afferent nociceptors. The downstream signaling processes that play a role in promoting this neuronal response remain however controversial. Increased TNF-a plasma levels during migraine attacks suggest that local interaction between this cytokine and intracranial meningeal nociceptors plays a role in promoting the headache. Here, using in vivo single unit recording in the trigeminal ganglia of anesthetized rats, we show that meningeal TNF-a action promotes a delayed mechanical sensitization of meningeal nociceptors. Using immunohistochemistry, we provide evidence for non-neuronal localization of the TNF receptors TNFR1 to dural endothelial vascular cells and TNFR2 to dural resident macrophages as well as to some CGRP-expressing dural nerve fibers. We also demonstrate that meningeal vascular TNFR1 is co-localized with COX-1 while the perivascular TNFR2 is co-expressed with COX-2. We further report here for the first time that TNF-a evoked sensitization of meningeal nociceptors is dependent upon local action of cyclooxygenase (COX). Finally, we show that local application of TNF-a to the meninges evokes activation of the p38 MAP kinase in dural blood vessels that also express TNFR1 and that pharmacological blockade of p38 activation inhibits TNF-a evoked sensitization of meningeal nociceptors. Our study suggests that meningeal action of TNF-a could play an important role in the genesis of intracranial throbbing headaches such as migraine through a mechanism that involves at least part activation of non-neuronal TNFR1 and TNFR2 and downstream activation of meningeal non-neuronal COX
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Introduction
Throbbing headaches of intracranial origin, such as migraine are mediated by primary afferent nociceptive neurons that innervate the intracranial meninges and their related large blood vessels [23, 27, 40] . Increased discharge of these meningeal nociceptors has been suggested to promote the ongoing headache while increases in their mechanosensitivity is believed to mediate the throbbing pain as well as the exacerbation of the headache during events that increase intracranial pressure. The endogenous processes that promote meningeal nociceptors' activation and mechanical sensitization during a headache episode remain speculative although local sterile meningeal inflammatory response has been suggested to play a critical role [18] .
One particular proinflammatory mediator, the cytokine tumor necrosis factor-a (TNF-a) has been shown to promote in vivo activation and sensitization of primary afferent nociceptors innervating the hind paw [4, 14] , as well as deep musculoskeletal [17] and cranial muscular tissues [11] . The finding of elevated levels of TNF-a in the internal jugular blood during migraine attacks [30, 34] and increases in its CSF levels in chronic migraine patients [33] point to TNF-a as a potential critical mediator of migraine pain. However, whether this cytokine affects the response properties of meningeal nociceptors is not known.
Under normal physiological conditions, TNF-a has been suggested to promote enhanced nociception primarily through the activation of the TNF receptor 1 (TNFR1) [7, 20, 36, 38] while under persistent injurious condition, activation of a second TNF receptor (TNFR2) has been implicated [4, 36] . The peripheral cell types that express TNF-a receptors and the downstream signaling processes that mediate the pro-nociceptive effect of TNF-a remain however highly controversial. In-vitro studies conducted on dorsal root and trigeminal ganglia neurons have suggested that the nociceptive effects of TNF-a are mediated through direct interaction with neuronal TNF receptors and the consequent activation of various downstream intracellular signaling cascades including among others TRPV1 channels [26] , TTX-resistant sodium channels [13] 
